Class B scavenger receptor family members, scavenger receptor B1 (SR-B1) and cluster of differentiation 36 (CD36), are broadly expressed cell-surface proteins, both of which are believed to serve as multifaceted players in lipid and lipoprotein metabolism in mammals. Because of its presence in the apical part of taste receptor cells within circumvallate taste buds and its ability to recognise long-chain fatty acids, CD36 has been believed to participate in the sensing of the lipid species within the oral cavity. However, there have been no attempts to address whether SR-B1 has such a role to date. In this study, by reverse transcription-polymerase chain reaction analysis, we detected SR-B1 mRNA in a total RNA sample isolated from the circumvallate papillae of mouse tongue. Immunohistochemical analysis of tongue sections from the animals revealed the expression of SR-B1 protein in a population of taste bud cells of circumvallate papillae. In addition, the pattern of staining in the papillae for SR-B1 agreed closely with that for CD36 in double immunostaining analysis. We performed a cell-free in-vitro assay utilising a peptide mimic of SR-B1 and provided evidence that the receptor could recognise certain of the unsaturated long-chain fatty acids such as oleic acid. Our present findings suggest an additional role for SR-B1 as a captor of specific fatty acids in the oral cavity of mammals and contribute to expanding our knowledge of the physiological function of the receptor.
Scavenger receptor B1 (SR-B1) is a cell-surface protein belonging to the class B scavenger receptor family, characterised by two predicted transmembrane spans, broad expression patterns and the ability to recognise diverse ligands (6, 12, 17) . SR-B1 ligands include high-density lipoprotein (HDL), low-density lipoprotein (LDL), acetylated LDL and oxidised LDL (oxLDL), suggesting that one of the primary roles of the receptor is to participate in lipoprotein metabolism (2, 3, 11) . In particular, much attention has been focused on its function as a physiologically relevant HDL receptor to mediate the selective delivery of HDL-cholesterol ester to hepatocytes and steroidogenic cells (2, 17) . Besides the welldocumented roles of SR-B1 in lipoprotein recognition and metabolism inside the body, our recent study provided the first evidence for the participation of the receptor in the capture of specific odouractive volatile compounds within the nasal cavity (28) . Indeed, we demonstrated the existence of SR-B1 protein in the superficial layer of main olfactory epithelium in mice and the ability of the receptor to recognise certain odorants such as tetradecanal and Z-11-hexadecenal (28) . Our findings would bring a new perspective to the physiological functions of SR-B1.
After dipping overnight at 4°C in 30% sucrose solution, the tissues were frozen in liquid nitrogen. Frozen sections were mounted on glass slides pre-coated with poly-L-lysine. After pre-treatment with PBS containing 0.3% v/v Triton X-100 (PBST) and normal donkey serum, the sections were incubated overnight with a rabbit anti-SR-B1 antibody (NB400-104; Novus Biologicals, Littleton, CO, USA) (1 : 200). After several washes with PBST, the sections were incubated with Alexa Fluor ® 488-labelled donkey anti-rabbit IgG (A-21206; Thermo Fisher Scientific Japan, Tokyo) (1 : 200). The sections were then mounted in glycerol/PBS and observed under a confocal laser-scanning microscope (FV1000; Olympus, Tokyo, Japan). For double immunofluorescence staining, the sections were incubated overnight with another rabbit anti-SR-B1 antibody (TA301489; OriGene, Rockville MD, USA) (1 : 200) and a goat anti-CD36 antibody (AF2519; R&D Systems, Minnesota, MN, USA) (1 : 200). They were then incubated with A-21206 (1 : 200) and Cy3-labelled donkey anti-goat IgG (705-165-147; Jackson ImmunoResearch, West Grove, PA, USA) (1 : 200). The stained sections were observed as described above. An oligopeptide containing amino acid residues 187 to 206 of human SR-B1 (SSSSSLVNLINKYFP GMFPFKDKFG) with biotin at the N-terminus was purchased from Life Technologies Japan (Tokyo), after synthesis (28) . Note that the first five Ser residues in the peptide have been introduced in the expectation that they would contribute in improving its solubility in aqueous solutions. The peptide was solubilised in dimethyl sulphoxide at a concentration of 1 mM, aliquoted and stored at −20°C until use. The procedure for labelling of human oxLDL (Biomedical Technologies, Stoughton, MA, USA) with the fluorescent dye AlexFluor ® 488 (Thermo Fisher Scientific Japan) was the same as described previously (15, (23) (24) (25) (26) (27) (28) . The fluorescently-labelled oxLDL (hereinafter fl-oxLDL) was stored at 4°C until use. LCFAs used were purchased from Sigma-Aldrich Japan (Tokyo). The purity of the LCFAs used was at least >98%. These were dissolved in ethanol at a concentration of 40 mM and stored at −20°C until use. Working solutions of LCFAs were prepared as follows: solutions of the test lipids dissolved in ethanol were sequentially diluted with ethanol. A 5-μL aliquot of the diluted lipids was placed in a 1.5-mL microcentrifuge tube, and 95 μL of a concentrated solution of PBS (1.05 × concentrate) containing 0.42% w/v bovine serum albumin (BSA; fatty acid free, Sigma-Aldrich Japan), 42 μM of butylated hydroxytoluene (Sigma-Aldrich Japan), 210 μM dieth-Cluster of differentiation 36 (CD36) is another member of class B scavenger receptors. In the past, most attention has been paid to the roles of the receptor in the capture and clearance of unwanted and harmful substances such as the oxLDL and advanced glycation end products in macrophages (3, 12, 19) and in the recognition and uptake of longchain fatty acids (LCFAs) in cells, including adipocytes (5, 13, 21) . Of interest are the findings that (i) the receptor exists in the apical part of mammalian taste bud cells (8, 16) and (ii) it plays a role in the chemosensory detection of LCFAs within the oral cavity, leading to an appetitive response to the lipid species, in rodents (1, 16) . Given that SR-B1 and CD36 share their ability to recognise various ligands, including oxLDL (4, 12) and specific aliphatic aldehydes (27, 28) , and are coexpressed in a number of tissues (12, 28) , it is possible that SR-B1 exists in the gustatory organ to participate in the oral sensing of LCFAs. However, there have been no attempts to address these issues to date. In the present study, we show the coexpression and colocalisation of SR-B1 with CD36 in the taste bud cells of circumvallate papillae in mice. Furthermore, we provide evidence that SR-B1 can recognise specific LCFAs such as oleic acid. Adult C57/BL6 mice (Shimizu Laboratory Supplies, Kyoto, Japan) were used for evaluating the expression and localisation of SR-B1 in the lingual epithelium of circumvallate papillae in this study. The usage of the animals in this study was approved by the Kyoto University Animal Experimentation Committee, and the experiments were in accordance with the Kyoto University Guidelines for the Ethical Treatment of Laboratory Animals. Circumvallate papillae were surgically isolated from the tongue using three mice. Total RNA was extracted from the pooled papillae (and liver) using the RNeasy Mini Kit (QIAGEN K. K.-Japan, Tokyo). Reverse transcription-polymerase chain reaction (RT-PCR) and agarose gel electrophoresis analyses were performed as described previously (18) . Primer sets (synthesised by Life Technologies Japan, Tokyo) used were as follows: 5′-TCAAGCAGCAGGTGCTCA-3′ and 5′-GAGGATTCGGGTGTCATGAA-3′ (28) . Immunohistochemical analyses were conducted as follows. Mice were perfused via the aorta with physiological saline solution, followed by 4% paraformaldehyde in phosphate buffered saline (PBS; 8 mM Na 2 HPO 4 , 1.5 mM KH 2 PO 4 , 136 mM NaCl and 2.7 mM KCl; pH 7.4, pH 7.4). Lingual tissues containing the circumvallate papillae were surgically removed and immersed in the same fixative for an additional 6 h. 104). Note that NB400-104 has been described to primarily label sinusoidal endothelial cells in liver as well as does the other anti-SR-B1 antibodies (9) , which illustrates the utility of the antibody for immunolocalisation of the receptor. Immunostaining of a tongue section with NB400-104 revealed the expression of SR-B1 protein in cells located within circumvallate taste buds (Fig. 1B) . It is noted that only a limited number of cells (at most a few) were immunolabelled in each of the individual taste buds and that the apical part was preferentially labelled in some of the immunoreactive cells ( Fig. 1B) . Together with the result of RT-PCR analysis, we concluded that SR-B1 is expressed in the taste bud cells of circumvallate papillae. To our knowledge, this is the first report showing the expression of the receptor in cells of the gustatory system. We also performed double immunostaining of sections from circumvallate papillae using another anti-SR-B1 antibody (TA301489) and an anti-CD36 antibody (AF2519). We have shown that the staining pattern of mouse liver with the anti-SR-B1 antibody (28) is nearly comparable to that with a few ones other than TA301489 (e.g., preferential labelling of outline of the cavities, which indicates SR-B1 expression in sinusoidal endothelial cells of the tissue) (9) . In addition, double immunostaining analysis with the SR-B1 and CD36 antibodies has uncovered a differential localisation of the receptors in murine nasal epithelium (28) . For instance, CD36 but not SR-B1 was found to localise in the somata of olfactory receptor cells (28) . An image obtained with TA301489 is illustrated in Fig. 1C (top panel) . The result was quite similar to that obtained using NB400-104 ( Fig. 1B) , further supporting the existence of SR-B1 in a population of taste bud cells. More notably, the pattern of staining for SR-B1 agreed well with that for CD36 (Fig. 1C , middle and bottom panels), indicating the coexpression and colocalisation of the receptors in the circumvallate papillae. CD36-immunopositive cells have been found to express α-gustducin, a marker protein of type II taste cells (i.e., taste receptor cells that are responsible for detection of sweet, bitter, and umami substances (20) ), in the murine circumvallate taste buds (16) . It is therefore expected that SR-B1-immunoreactive cells are the receptor cells of the tongue. It is believed that (i) SR-B1 and CD36 bind oxLDL by recognising oxidised glycerophosphocholine species having a terminal γ-hydroxyl(or oxo)α,β-unsaturated carbonyl on the sn-2 acyl group (hereinafter oxGPC SRB ), which occur on the surface of the lipoprotein particles, and (ii) the amino acid ylenetriamine penta-acetic acid (Dojindo, Kumamoto, Japan) and 10.5 μg protein/mL of fl-oxLDL was added, and used in the assay. The wells of a 96-well plate pre-coated with streptavidin (Thermo Fisher Scientific Japan) were pre-washed thrice with PBS containing 0.4% w/v BSA (hereafter referred to as PBS-BSA). A 0.05-mL aliquot of PBS-BSA alone or PBS-BSA containing synthetic peptides at a concentration of 5 μM was added to each well of the plate. Subsequently, the plate was incubated at an ambient temperature for 1 h with gentle shaking. After washing the wellplate thrice with PBS containing 0.05% w/v BSA, untreated wells and wells pre-treated with the peptide received 0.05 mL of the working solutions described above. The plate was then incubated in the dark at an ambient temperature for 1 h with gentle shaking. After incubation, each of the wells was washed thrice with 0.2 mL of PBS, followed by addition of 0.1 mL of PBS. The fluorescence in each well was measured using a multi-well plate reader (PowerScan; Dainippon Sumitomo Pharma, Osaka, Japan) at an excitation wavelength of 485 nm and an emission wavelength of 528 nm. At each of the fatty acid concentrations, the fluorescence values for wells pre-treated with peptides were obtained by subtracting the mean fluorescence value of peptide-untreated wells. Prism ® software (version 7.0d; GraphPad, San Diego, CA, USA) was used to determine the concentration required for 50% inhibition of binding (IC 50 ) and the coefficient determination (R 2 ). By RT-PCR analysis using a primer set described above, we have detected mRNA for SR-B1 in total RNA samples extracted from mouse nasal mucosa and liver (a reference tissue for SR-B1 mRNA expression (9)) (28) . In the present study, we performed the same analysis on a sample isolated from the circumvallate papillae of mouse tongue. We detected an amplicon of the expected size for SR-B1 mRNA (706 bp) in the sample as well as in a liver sample (Fig. 1A) . No band was detected from the lingual sample (and liver sample) when the RT-PCR mixture was prepared without reverse transcriptase (Fig. 1A) . These results indicated the expression of SR-B1 mRNA in the circumvallate papillae of the animals. CD36 has been demonstrated to exist in a population of cells within circumvallate taste buds of rats and mice (8, 16) . In the present study, we assessed the expression and distribution of SR-B1 protein in mouse circumvallate papillae by immunohistochemical staining using an anti-SR-B1 antibody (NB400- In the present study, we provided evidence that (i) SR-B1 is expressed in a population of the taste bud cells of circumvallate papillae in mice and (ii) the receptor could serve as the receptor for certain of the unsaturated LCFAs like oleic acid. Our findings suggest a novel role for SR-B1 as a captor of specific LCFAs in the oral cavity of mammals. It is, however, unclear whether SR-B1-dependent capture of LCFAs by taste bud cells is linked to the chemosensory perception of the lipid species. Several studies have implicated the involvement of CD36 in LCFAs-activated intracellular signalling events (e.g., a rise in intracellular calcium concentration) in human and mouse taste bud cells, which leads to the sensory perception of the lipid species (7, 22) . Defining the importance of SR-B1 in the orosensory detection of LCFAs awaits further investigation. Furthermore, it remains uncertain whether unsaturated LCFAs directly bind to b-SR-B1 187-206 to compete against fl-oxLDL binding. There remains the possibility that the unsaturated LCFAs tested at high micromolar concentrations merely denature fl-oxLDL to inhibit binding to the peptide. Assays to demonstrate the direct binding of LCFAs to the SR-B1 peptide should be performed. Regardless, our present findings on SR-B1 would make a contribution to expanding our knowledge of the function of the receptor.
183-205 of SR-B1 and amino acid 157-171 of CD36 are responsible for recognising oxGPC SRB (10, 14, 19) . Also, we have shown that (i) fl-oxLDL binds specifically to N-terminal biotinylated peptides containing residues 187 to 206 of human SR-B1 (designated b-SR-B1 187-206 in this study) and those 150 to 168 of human or mouse CD36 immobilised onto streptavidin-precoated plates and (ii) oxGPC SRB species such as 1-(palmitoyl)-2-(5-keto-6-octenedioyl) phosphatidylcholine inhibit the binding of fl-oxLDL to the SR-B1 and CD36 peptides (15, 23-25, 27, 28) . More importantly, we have found that unsaturated LCFAs such as oleic and linoleic acids (but not saturated ones such as palmitic and stearic acids) inhibit the binding of fl-oxLDL to peptide mimics of CD36 (15, 23) , providing additional evidence for the interaction between CD36 and the lipid species. In contrast, there have been no attempts to explore whether SR-B1 serves as the receptor for LCFAs. In this study, we aimed to assess interaction between SR-B1 and LCFAs by evaluating the ability of the lipid species to inhibit the binding of fl-oxLDL to b-SR-B1 187-206 . We selected oleic (C18:1), linoleic (C18:2), palmitic acid (C16:0) and stearic (C18:0) acids as test LCFAs. Each of the two unsaturated LCFAs inhibited fl-oxLDL binding to b-SR-B1 187-206 in a concentration-dependent manner (Fig. 2) . The IC 50 values for oleic and linoleic acids were determined to be 0.61 (R 2 = 0.96) and 0.56 mM (R 2 = 0.95), respectively. On the other hand, the saturated LCFAs tested only exhibited very weak inhibitory activities (Fig. 2) . The IC 50 values for palmitic and stearic acids were 4.2 (R 2 = 0.62) and 8.6 mM (R 2 = 0.71), respectively. These results are considerably different from those obtained using a peptide containing amino acid residues 150 to 168 of mouse CD36 (the sequence: QNSFVQVVLNSLIKKSKSS): oleic acid inhibited fl-oxLDL binding to the peptide mimic of CD36 more strongly than did linoleic acid (IC 50 values for oleic and linoleic acid were 0.25 and 0.97 mM, respectively); and palmitic and stearic acids showed no inhibitory activities at any concentrations tested (23) . This may be primarily due to differences in the amino acid sequences between the SR-B1 and CD36 peptides. For instance, the SR-B1 peptide has Pro residues, whereas the CD36 one does not (23, 28) . We will have to identify the residues that account for the differences in the reactivity with LCFAs. Nonetheless, based on the data obtained, we concluded that the unsaturated LCFAs could be recognised by SR-B1, while the saturated ones not effectively. were incubated with fl-oxLDL in the absence or presence of the LCFAs at the indicated concentrations. Fluorescence values were obtained as described in the text. The mean fluorescence of wells incubated with fl-oxLDL alone was set at 100. Data are expressed as mean ± S.D. for three independent wells.
